These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25188859)
1. HBV and HIV coinfections among intending blood donors in Port Harcourt, Nigeria. Okonko IO; Horsefall SJ; Okerentugba PO; Frank-Peterside N J Immunoassay Immunochem; 2015; 36(4):359-67. PubMed ID: 25188859 [TBL] [Abstract][Full Text] [Related]
2. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon. Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526 [TBL] [Abstract][Full Text] [Related]
3. The prevalence of hepatitis B surface antigen (HBsAg) among prospective blood donors and patients in Port Harcourt, Nigeria. Ejele OA; Ojule AC Niger J Med; 2004; 13(4):336-8. PubMed ID: 15523857 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745 [TBL] [Abstract][Full Text] [Related]
5. Sero-prevalence of hepatitis B surface antigen (HBsAg) in pregnant women in Port Harcourt, Nigeria. Akani CI; Ojule AC; Opurum HC; Ejilemele AA Niger Postgrad Med J; 2005 Dec; 12(4):266-70. PubMed ID: 16380737 [TBL] [Abstract][Full Text] [Related]
6. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria. Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677 [TBL] [Abstract][Full Text] [Related]
7. The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria. Ejele OA; Nwauche CA; Erhabor O Niger J Med; 2004; 13(2):175-9. PubMed ID: 15293840 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria. Uneke CJ; Ogbu O; Inyama PU; Anyanwu GI; Njoku MO; Idoko JH Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):13-6. PubMed ID: 15867956 [TBL] [Abstract][Full Text] [Related]
9. Coinfection of Human Immunodeficiency Virus-Infected Patients with Hepatitis B Virus in Lokoja, North Central Nigeria. Omatola CA; Okolo MO; Adaji DM; Mofolorunsho CK; Abraham Oyiguh J; Zige DV; Akpala NS; Ocholi Samson S Viral Immunol; 2020 Jun; 33(5):391-395. PubMed ID: 32031904 [TBL] [Abstract][Full Text] [Related]
10. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. Cunha L; Plouzeau C; Ingrand P; Gudo JP; Ingrand I; Mondlane J; Beauchant M; Agius G J Med Virol; 2007 Dec; 79(12):1832-40. PubMed ID: 17935167 [TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of HBV among people living with HIV in Anyigba, Kogi State, Nigeria. Omatola CA; Idofe J; Okolo MO; Adejo PO; Maina MM; Oyiguh JA Afr Health Sci; 2019 Jun; 19(2):1938-1946. PubMed ID: 31656477 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of HIV/HBV coinfection in Malian blood donors. Tounkara A; Sarro YS; Kristensen S; Dao S; Diallo H; Diarra B; Noumsi TG; Guindo O J Int Assoc Physicians AIDS Care (Chic); 2009; 8(1):47-51. PubMed ID: 19182212 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria. Egah DZ; Banwat EB; Audu ES; Iya D; Mandong BM; Anele AA; Gomwalk NE East Mediterr Health J; 2007; 13(4):961-6. PubMed ID: 17955779 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis infections among blood donors at the Muhimbili National Hospital in Dar es Salaam, Tanzania. Matee MI; Magesa PM; Lyamuya EF BMC Public Health; 2006 Jan; 6():21. PubMed ID: 16445860 [TBL] [Abstract][Full Text] [Related]
15. [Prevalence and incidence of HIV and hepatitis B among blood donors and estimated residual risk of transmission of HIV and HBV virus by blood transfusion. A study at the Provincial General Referee Hospital Bukavu, Democratic Republic of the Congo]. Namululi BA; Guerrieri C; Dramaix MW Rev Epidemiol Sante Publique; 2013 Apr; 61(2):139-44. PubMed ID: 23498094 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria. Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya. Daw MA; Shabash A; El-Bouzedi A; Dau AA; PLoS One; 2014; 9(6):e98793. PubMed ID: 24936655 [TBL] [Abstract][Full Text] [Related]
18. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico]. Carreto-Vélez MA; Carrada-Bravo T; Martínez-Magdaleno A Salud Publica Mex; 2003; 45 Supp 5():S690-3. PubMed ID: 14974281 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Alikor EA; Erhabor ON Niger J Med; 2007; 16(4):326-9. PubMed ID: 18080589 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi. Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]